VETIVD™, which has made major breakthroughs in the field of animal diagnosis and treatment, recently announced that after 12 months of rigorous clinical trials, the canine leishmania immunofluorescence detection reagent it developed has successfully passed clinical verification by the School of Veterinary Medicine at the University of Messina. This result will Provide strong support for canine leishmaniasis prevention and control efforts worldwide.

《Validation of a new rapid immunochromatographic test for Leishmania infantum diagnosis of in dogs》

Canine leishmaniasis is a serious parasitic disease caused by Leishmania protozoa, which poses a huge threat to the health of dogs. The disease is widespread worldwide, and its diagnosis and treatment have been important challenges for the animal medicine community. The immunofluorescence detection reagent developed by VETIVD™ can quickly and accurately detect whether dogs are infected with Leishmania through innovative immunofluorescence technology, providing veterinarians with timely and reliable diagnostic basis.

The School of Veterinary Medicine at the University of Messina is an internationally renowned animal medical research institution, and the authority and credibility of its clinical verification results are self-evident. After rigorous clinical experiments and data analysis, the reagent showed excellent performance in terms of sensitivity, specificity and accuracy, and was successfully recognized by the School of Veterinary Medicine at the University of Messina.

VETIVD™ stated that the success of this clinical verification not only proves the company’s strong R&D strength, but also marks an important step in the field of animal diagnosis and treatment. In the future, the company will continue to be committed to the research, development and innovation of animal diagnosis and treatment technology, and contribute more to the global animal health cause.

The clinically verified canine leishmania immunofluorescence detection reagent will provide veterinarians around the world with a more convenient and efficient diagnostic tool, which will help timely detect and treat canine leishmaniasis and reduce the spread and harm of the disease. At the same time, this will also inject new vitality into the development of the field of animal diagnosis and treatment and promote the continuous development of this field.

With the continuous advancement and innovation of animal diagnosis and treatment technology, we have reason to believe that the animal health industry will usher in a better tomorrow. This major breakthrough of VETIVD™ is undoubtedly a solid step towards the realization of this beautiful vision.